Phibro Animal Health reported $22.89M in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Align Technology ALGN:US USD 143.66M 44.54M
Ani Pharmaceuticals ANIP:US USD -4995000 7.92M
Aurora Cannabis Inc ACB:CN CAD -54500000 570.08M
Bristol Myers Squibb BMY:US USD 2.47B 117M
Canopy Growth Corp WEED:CN CAD -159665000 1.7B
Corcept Therapeutics CORT:US USD 31.93M 502K
Depomed DEPO:US USD 6.43M 4.36M
Eli Lilly And LLY:US USD 1.68B 466.4M
Endo International Ordinary Shares ENDP:US USD -636822000 1.1B
Henry Schein HSIC:US USD 211M 9M
Idexx Laboratories IDXX:US USD 244.83M 65.76M
Knight Therapeutics Inc GUD:CN CAD -11333000 14.22M
Lannett LCI:US USD -13028000 64.93M
Merk MRK:US USD 3.99B 939M
Nektar Therapeutics NKTR:US USD -54301000 98.54M
Pacira Pharmaceuticals PCRX:US USD 21.29M 9.95M
Patterson Companies PDCO:US USD 34.84M 37.99M
Prestige Brands PBH:US USD 84.38M 2.63M
Supernus Pharmaceuticals SUPN:US USD -1523000 12.87M
Teva Pharmaceutical Industries TEVA:US USD 419M 1.37B
Zoetis ZTS:US USD 667M 3M